Eton Pharmaceuticals Inc (ETON)


Stock Price Forecast

March 28, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Eton Pharmaceuticals Inc chart...

About the Company

eton pharmaceuticals, inc. is a deer park, illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the u.s. food and drug administration’s 505(b)(2) regulatory pathway. our mission is to advance healthcare through the introduction of innovative medicines that are affordable and available to all patients.

Exchange

NASDAQ

Website

etonpharma.com

$34M

Total Revenue

39

Employees

$97M

Market Capitalization

-164.94

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ETON News

Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...

14d ago, source:

Revenue Growth: Q4 product sales and royalty revenue surged by 109% year-over-year to $7.3 million. Positive Cash Flow: ETON ...

Eton Pharmaceuticals Inc ETON

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Eton Pharma Buys U.S. Rights To PKU GOLIKE From Relief Therapeutics

6d ago, source: Nasdaq

(RTTNews) - Eton Pharmaceuticals Inc (ETON) said that it has acquired U.S. rights to PKU GOLIKE from Relief Therapeutics Holding SA. PKU is a rare inherited disorder caused by a defect in the ...

Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE

6d ago, source:

GENEVA, SWITZERLAND / ACCESSWIRE / /RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the ...

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

14d ago, source: Business Insider

March 14, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing ...

Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules

27d ago, source: ADVFN

For more detailed information, please see full Prescribing Information for more information.To report a suspected adverse event related to Nitisinone, contact Eton Pharmaceuticals, Inc. at ...

Eton Pharma Buys U.S. Rights To PKU GOLIKE From Relief Therapeutics

6d ago, source:

Eton Pharmaceuticals Inc (ETON) said that it has acquired U.S. rights to PKU GOLIKE from Relief Therapeutics Holding SA. PKU is a ...

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates

14d ago, source: Zacks.com on MSN

Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.04 per share a year ago.

Eton Pharmaceuticals Inc

21d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...